ArticleLife (Basel, Switzerland)2023

Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study.

Fulvia Ceccarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.